01954oam 2200601 450 991070699750332120190624132607.0(CKB)5470000002459498(OCoLC)1029561452(EXLCZ)99547000000245949820180326d2018 ua 0engurbn||||a||||txtrdacontentcrdamediacrrdacarrierExamining HRSA's oversight of the 340B Drug Pricing Program hearing before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives, One Hundred Fifteenth Congress, first session, July 18, 2017Washington :U.S. Government Publishing Office,2018.1 online resource (iii, 104 pages) illustrations"Serial No. 115-46."Includes bibliographical references.Examining HRSA's oversight of the 340B Drug Pricing Program Prescription pricingGovernment policyUnited StatesPoorPharmaceutical assistanceUnited StatesOlder peoplePharmaceutical assistanceUnited StatesLegislative hearings.lcgftPrescription pricingGovernment policyPoorPharmaceutical assistanceOlder peoplePharmaceutical assistanceGPOGPOGPOMERUCOCLCFUOKGPOINTGPOOCLCQOCLCOOCLCAGPOTEUOCLCOIASOCLCOTXROCLCOGPOBOOK9910706997503321Examining HRSA's oversight of the 340B Drug Pricing Program3510702UNINA